Cowen Resumes Coverage on LeMaitre Vascular (LMAT) at Outperform
More News related to LMAT
- LeMaitre Vascular to Present At Canaccord Adams 28th Annual Global Growth Conference
- LeMaitre Vascular Receives Notice of Noncompliance With Nasdaq Marketplace Rule
- LeMaitre Vascular (LMAT) Reports Q2 Loss of $0.06, Misses by a Penny
- LeMaitre Vascular Reports Q2 2008 Revenue of $12.7 Million, a 23% Increase
- LeMaitre Vascular, Inc. Schedules Second Quarter Results and Conference Call
Cowen & Co resumes coverage on LeMaitre Vascular, Inc. (Nasdaq: LMAT) with an Outperform rating, saying the company is poised in the coming quarters to post substantially improved performance.
The firm said, "Our belief that the company is about to turn the corner with regard to its P&L coupled with a significantly discounted valuation (1x EV/08 revs) has led us to initiate coverage of LMAT shares with an Outperform rating."
Related Categories
New CoverageStocks Mentioned
-0.01Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
